Vitamin D-directed rheostatic regulation of monocyte antibacterial responses

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4289-4295

  Adams, John S ^a,b   Ren, Songyang ^a   Liu, Philip T ^a   Chun, Rene F ^a   Lagishetty, Venu ^a   Gombart, Adrian F ^c   Borregaard, Niels ^d   Modlin, Robert L ^a   Hewison, Martin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; ERGOCALCIFEROL; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; 1,25-DIHYDROXYVITAMIN D; ANTIMICROBIAL CATIONIC PEPTIDE; CALCIDIOL 1 MONOOXYGENASE; DRUG DERIVATIVE; MESSENGER RNA; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BIOSYNTHESIS; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 64249131549     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803736     Document Type: Article

References (30)

1. Adams, J. S., and M. Hewison. 2008. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metabol. 4: 80-90.
2. Adams, J. S., P. Liu, R. Chun, R. L. Modlin, and M. Hewison. 2007. Vitamin D in defense of the human immune response. Ann. NY Acad. Sci. 1117: 94-105. (Pubitemid 350191275)
3. Liu, P. T., S. R. Krutzik, and R. L. Modlin. 2007. Therapeutic implications of the TLR and VDR partnership. Trends Mol. Med. 13: 117-124.
4. Hewison, M., F. Burke, K. N. Evans, D. A. Lammas, D. M. Sansom, P. Liu, R. L. Modlin, and J. S. Adams. 2007. Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 103: 316-321. (Pubitemid 46420518)
5. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
6. Hewison, M., L. Freeman, S. V. Hughes, K. N. Evans, R. Bland, A. G. Eliopoulos, M. D. Kilby, P. A. Moss, and R. Chakraverty. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170: 5382-5390. (Pubitemid 36617823)
7. Fritsche, J., K. Mondal, A. Ehrnsperger, R. Andreesen, and M. Kreutz. 2003. Regulation of 25-hydroxyvitamin D3-1 α-hydroxylase and production of 1 α,25-dihydroxyvitamin D3 by human dendritic cells. Blood 102: 3314-3316. (Pubitemid 37314772)
8. Sigmundsdottir, H., J. Pan, G. F. Debes, C. Alt, A. Habtezion, D. Soler, and E. C. Butcher. 2007. DCs metabolize sunlight-induced vitamin D3 to "program" T cell attraction to the epidermal chemokine CCL27. Nat. Immunol. 8: 285-293.
9. Chen, S., G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky. 2007. Modulatory effects of 1,25-dihydroxyvitamin d3 on human B cell differentiation. J. Immunol. 179: 1634-1647.
10. Millen, A. E., and L. M. Bodnar. 2008. Vitamin D assessment in population-based studies: a review of the issues. Am. J. Clin. Nutr. 87: 1102S-1105S.
11. Holick, M. F. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266-281.
12. Sorensen, O., J. B. Cowland, J. Askaa, and N. Borregaard. 1997. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J. Immunol. Methods 206: 53-59. (Pubitemid 27395865)
13. Wu, S., S. Ren, L. Nguyen, J. S. Adams, and M. Hewison. 2007. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 148: 3410-3418. (Pubitemid 46997000)
14. Evans, K. N., L. Nguyen, J. Chan, B. A. Innes, J. N. Bulmer, M. D. Kilby, and M. Hewison. 2006. Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol. Reprod. 6: 816-822. (Pubitemid 44845586)
15. Martineau, A. R., R. J. Wilkinson, K. A. Wilkinson, S. M. Newton, B. Kampmann, B. M. Hall, G. E. Packe, R. N. Davidson, S. M. Eldridge, Z. J. Maunsell, et al. 2007. A single dose of vitamin d enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med. 176: 208-213.
16. Nursyam, E. W., Z. Amin, and C. M. Rumende. 2006. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones. 38: 3-5.
17. Chapuy, M. C., P. Preziosi, M. Maamer, S. Arnaud, P. Galan, S. Hercberg, and P. J. Meunier. 1997. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 7: 439-443. (Pubitemid 27443069)
18. Thomas, M. K., D. M. Lloyd-Jones, R. I. Thadhani, A. C. Shaw, D. J. Deraska, B. T. Kitch, E. C. Vamvakas, I. M. Dick, R. L. Prince, and J. S. Finkelstein. 1998. Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338: 777-783.
19. Holick, M. F., E. S. Siris, N. Binkley, M. K. Beard, A. Khan, J. T. Katzer, R. A. Petruschke, E. Chen, and A. E. de Papp. 2005. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J. Clin. Endocrinol. Metab. 90: 3215-3224. (Pubitemid 41014278)
20. Heaney, R. P., M. S. Dowell, C. A. Hale, and A. Bendich. 2003. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J. Am. Coll. Nutr. 22: 142-146.
21. Dawson-Hughes, B., R. P. Heaney, M. F. Holick, P. Lips, P. J. Meunier, and R. Vieth. 2005. Estimates of optimal vitamin D status. Osteoporosis Int. 16: 713-716.
22. Nesby-O'Dell, S., K. S. Scanlon, M. E. Cogswell, C. Gillespie, B. W. Hollis, A. C. Looker, C. Allen, C. Doughertly, E. W. Gunter, and B. A. Bowman. 2002. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 76: 187-192. (Pubitemid 34686565)
23. Dawson-Hughes, B., and H. A. Bischoff-Ferrari. 2007. Therapy of osteoporosis with calcium and vitamin D. J. Bone Mineral Res. 22 Suppl. 2: V59-63.
24. Liu, P. T., S. Stenger, D. H. Tang, and R. L. Modlin. 2007. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179: 2060-2063.
25. Wang, T. T., F. P. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J. W. Hanrahan, S. Mader, and J. H. White. 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173: 2909-2912.
26. Gombart, A. F., N. Borregaard, and H. P. Koeffler. 2005. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19: 1067-1077.
27. Martineau, A. R., K. A. Wilkinson, S. M. Newton, R. A. Floto, A. W. Norman, K. Skolimowska, R. N. Davidson, O. E. Sorensen, B. Kampmann, C. J. Griffiths, and R. J. Wilkinson. 2007. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 178: 7190-7198.
28. Islam, D., L. Bandholtz, J. Nilsson, H. Wigzell, B. Christensson, B. Agerberth, and G. Gudmundsson. 2001. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7: 180-185. (Pubitemid 32148484)
29. Chakraborty, K., S. Ghosh, H. Kole, A. K. Mukhopadhyay, T. Ramamurthy, D. R. Saha, D. Mukhopadhyay, S. Roychowdhury, T. Hamabata, Y. Takeda, and S. Das. 2008. Bacterial exotoxins downregulate cathelicidin (hCAP18/LL37) and human β-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol. 10: 2520-2537.
30. Vieth, R. 2006. What is the optimal vitamin D status for health? Prog. Biophys. Mol. Biol. 92: 26-32. (Pubitemid 43842065)